Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Cheng Andrew Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 Cheng Andrew (President and CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 8,868 shares @ $46.057, valued at $408.4k
Sold 5,300 shares @ $46.8836, valued at $248.5k
Sold 2,662 shares @ $48.5632, valued at $129.3k
Sold 1,700 shares @ $49.7059, valued at $84.5k
Sold 6,470 shares @ $50.5619, valued at $327.1k
Exercised 25,000 options to buy @ $6.36, valued at $159k
10/02/2023 144 Form 144 - Report of proposed sale of securities:
08/03/2023 4 Cheng Andrew (President and CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 13,679 shares @ $42.8514, valued at $586.2k
Sold 11,321 shares @ $43.5211, valued at $492.7k
Exercised 25,000 options to buy @ $6.36, valued at $159k
07/06/2023 4 Cheng Andrew (President and CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 18,730 shares @ $44.6606, valued at $836.5k
Sold 5,051 shares @ $45.3615, valued at $229.1k
Sold 1,219 shares @ $46.2896, valued at $56.4k
Exercised 25,000 options to buy @ $6.36, valued at $159k
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/15/2023 4 Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 1,613 shares @ $55.16, valued at $89k
06/05/2023 4 Cheng Andrew (President and CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 3,914 shares @ $44.1752, valued at $172.9k
Sold 20,686 shares @ $45.2562, valued at $936.2k
Sold 400 shares @ $45.897, valued at $18.4k
Exercised 21,330 options to buy @ $0.615, valued at $13.1k
Exercised 3,670 options to buy @ $6.36, valued at $23.3k
05/03/2023 4 Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 21,523 shares @ $45.0049, valued at $968.6k
Sold 3,477 shares @ $45.5045, valued at $158.2k
Exercised 40,000 options to buy @ $0.615, valued at $24.6k
Exercised 25,000 options to buy @ $0.615, valued at $15.4k
04/05/2023 4 Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 23,292 shares @ $37.8783, valued at $882.3k
Sold 1,708 shares @ $38.8259, valued at $66.3k
Exercised 25,000 options to buy @ $0.615, valued at $15.4k
04/03/2023 144 Form 144 - Report of proposed sale of securities:
03/14/2023 4 Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,706 shares @ $43.47, valued at $74.2k
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2023 4 Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 13,200 shares @ $50.1199, valued at $661.6k
Sold 3,800 shares @ $50.8194, valued at $193.1k
Sold 3,000 shares @ $52.0319, valued at $156.1k
Sold 800 shares @ $53.0878, valued at $42.5k
Sold 3,900 shares @ $54.371, valued at $212k
Sold 300 shares @ $54.8067, valued at $16.4k
Exercised 25,000 options to buy @ $0.615, valued at $15.4k
12/20/2022 4 Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Granted 87,220 options to buy @ $21.1, valued at $1.8M
Exercised 8,500 options to buy @ $0.615, valued at $5.2k
12/13/2022 4 Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Granted 52,351 shares @ $0
Granted 235,580 options to buy @ $42.95, valued at $10.1M
12/02/2022 4 Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 10,000 shares @ $46.07, valued at $460.7k
Exercised 10,000 options to buy @ $0.615, valued at $6.2k
11/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2022 4 Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 4,550 shares @ $32.8, valued at $149.2k
Sold 5,350 shares @ $33.57, valued at $179.6k
Sold 100 shares @ $34.39, valued at $3.4k
Exercised 10,000 options to buy @ $0.615, valued at $6.2k
09/15/2022 4 Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 16,796 shares @ $26.74, valued at $449.1k
Sold 43,204 shares @ $27.69, valued at $1.2M
Exercised 60,000 options to buy @ $0.615, valued at $36.9k
09/13/2022 4 Cheng Andrew (President and CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Granted 1,152 shares @ $8.03, valued at $9.3k
Granted 87,221 options to buy @ $21.1, valued at $1.8M
Granted 87,221 options to buy @ $21.1, valued at $1.8M
05/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/11/2022 4 Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 10,000 shares @ $19.55, valued at $195.5k
Exercised 10,000 options to buy @ $0.615, valued at $6.2k
01/04/2022 4 Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Exercised 53,000 options to buy @ $0.615, valued at $32.6k
12/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/03/2021 4 Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 17,500 shares @ $22.57, valued at $395k
10/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2021 4 Cheng Andrew (Director) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Converted 17,488 shares @ $0
Converted 17,488 preferred shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy